Trial Outcomes & Findings for Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization (NCT NCT00074724)
NCT ID: NCT00074724
Last Updated: 2021-04-08
Results Overview
COMPLETED
NA
319 participants
3 years
2021-04-08
Participant Flow
Participant milestones
| Measure |
Medical Therapy
All medical interventions know to improve outcomes in patients with ischemic left ventricular dysfunction.
Modern medical management: Therapies with evidence-based recommendations.
Dobutamine echocardiography: Incremental dose administration of dobutamine to elicit a contractile response of the myocardium.
Optimal medical therapy: All medical interventions known to improve outcomes in patients with ischemic left ventricular dysfunction.
|
CABG
Surgical revascularization in conjunction with optimal medical therapy.
Coronary Artery Bypass: coronary revascularization using arterial or vein conduits
Dobutamine echocardiography: Incremental dose administration of dobutamine to elicit a contractile response of the myocardium.
|
|---|---|---|
|
Overall Study
STARTED
|
0
|
0
|
|
Overall Study
COMPLETED
|
0
|
0
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Dobutamine Echocardiography In Patients With Ischemic Heart Failure Evaluated for Revascularization
Baseline characteristics by cohort
Baseline data not reported
PRIMARY outcome
Timeframe: 3 yearsPopulation: The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 4 months and 2 yearsPopulation: The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available
Outcome measures
Outcome data not reported
Adverse Events
Medical Therapy
CABG
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Scientific Center Administrator
MedStar Health Research Institute
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place